Emergent BioSolutions Sees FY23 Revenue $1B-$1.1B Vs $1.16B Est
Portfolio Pulse from Benzinga Newsdesk
Emergent BioSolutions has projected its FY23 revenue to be between $1B and $1.1B, which is lower than the estimated $1.16B.
August 08, 2023 | 9:24 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Emergent BioSolutions' lower than expected FY23 revenue forecast could negatively impact its stock price.
Emergent BioSolutions' projected revenue for FY23 is lower than the estimated $1.16B. This could lead to a negative sentiment among investors, potentially causing a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100